Provention Bio Inc. (PRVB) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Provention Bio Inc.

    NASDAQ: PRVB · Real-Time Price · USD
    24.98
    0.00 (0.00%)
    At close: Apr 26, 2023, 10:00 PM

    Provention Bio Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 44.04M 102.38M 57.88M 74.91M 78.19M 139.34M 151.78M 180.36M
    Short-Term Investments
    		 120.96M 83.14M 26.64M 10.13M 16.92M 11.43M 24.6M 26.85M
    Long-Term Investments
    		 n/a 1.01M 11.61M 28.32M 32.02M n/a n/a n/a
    Other Long-Term Assets
    		 120K 120K 120K 120K 120K 120K 120K 120K
    Receivables
    		 1.36M n/a n/a n/a n/a n/a n/a n/a
    Inventory
    		 1.23M n/a n/a n/a n/a n/a n/a n/a
    Other Current Assets
    		 7.06M 4.91M 5.78M 6.74M 5.99M 4.49M 4.21M 4.45M
    Total Current Assets
    		 174.65M 190.43M 90.31M 91.79M 101.1M 155.26M 180.59M 211.65M
    Property-Plant & Equipment
    		 2.53M 2.35M 2.31M 2.24M 2.38M 2.49M 2.6M 2.02M
    Goodwill & Intangibles
    		 59.56M n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 62.21M 3.48M 14.05M 30.67M 34.52M 2.61M 2.72M 2.13M
    Total Assets
    		 236.86M 193.91M 104.35M 122.46M 135.62M 157.88M 183.31M 213.79M
    Account Payables
    		 6.76M 3.79M 5.66M 7.24M 3.55M 3.63M 3.87M 8.28M
    Deferred Revenue
    		 17.69M 7.78M 7.28M 7.37M 5.6M 5.49M 7M 4.52M
    Short-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Current Liabilities
    		 65.94M 13.55M 12.22M 12.43M 13.65M 11.68M 13.77M 13.95M
    Total Current Liabilities
    		 90.39M 25.12M 25.15M 27.05M 22.79M 20.81M 24.63M 26.75M
    Long-Term Debt
    		 23.91M 23.78M 518K 555K 590K 624K 655K 686K
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 24.62M 24.03M 518K 1.21M 2.1M 2.95M 655K 3.17M
    Total Liabilities
    		 115.01M 49.14M 25.67M 28.25M 24.89M 23.76M 25.29M 29.92M
    Total Debt
    		 23.91M 23.78M 518K 555K 590K 624K 655K 686K
    Common Stock
    		 9K 9K 7K 6K 6K 6K 6K 6K
    Retained Earnings
    		 -405.64M -372.36M -343.73M -314.04M -292.07M -266.25M -239.22M -210.08M
    Comprehensive Income
    		 -647K -886K -841K -714K -139K -3K 12K -16K
    Shareholders Equity
    		 121.85M 144.77M 78.68M 94.21M 110.73M 134.11M 158.02M 183.87M
    Total Investments
    		 120.96M 84.15M 38.25M 38.45M 48.94M 11.43M 24.6M 26.85M

    Add to Watchlist